Thorium-228 Market Outlook: Demand Trends in Nuclear Medicine and Research
.png)
Global Thorium-228 market is experiencing significant growth, with a valuation of USD 1.9 million in 2024 projected to reach USD 3.1 million by 2031 , growing at a CAGR of 7.0% . This expansion is primarily driven by increasing applications in nuclear medicine, particularly in targeted alpha therapy for cancer treatment. As healthcare systems worldwide prioritize advanced radiotherapy solutions, demand for this radioactive isotope continues to rise. Thorium-228 , a byproduct of actinium-227 production, offers unique therapeutic properties when processed into radium-224/lead-212 generators. Its ability to deliver precise radiation doses to cancerous cells while sparing healthy tissue makes it invaluable in oncology. However, strict handling protocols and extended storage requirements (10-20 years) due to its radioactive nature create unique market challenges. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/294230/thorium-forecast-market Market Overview ...